Manufacturers Life Insurance Company, The Ironwood Pharmaceuticals Inc Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 52,943 shares of IRWD stock, worth $79,414. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,943
Previous 54,522
2.9%
Holding current value
$79,414
Previous $224,000
4.46%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding IRWD
# of Institutions
244Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$34.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$29.3 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$24.6 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$17.6 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$14.2 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $230M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...